Skip to main content

Table 1 Descriptive statistics

From: A clinical study of inferior alveolar nerve damage caused by Carnoy’s solution used as a complementary therapeutic agent in a cystic lesion

VariablesAttributes
Categorical variables
 SexMales: 57 (74%)
Females: 20 (26%)
 CS useCS use: 19 (24.7%)
No use: 58 (75.3%)
 Sensory recoveryNormal (NRS = 8–10): 57 (74%)
Not normal (NRS = below 8): 20 (26%)
 DiagnosisOKC: 14 (18.2%), UAM: 5 (6.5%), DC: 30 (39%), RC: 28 (36.4%)
Interval variablesMinimumMaximumMeanStd. deviation
 Age117639.5614.42
 Follow-up period in months106636.9613.91
 Invasion size131.910.83
 NRS right after cyst enucleation    
 Total (77)02107.942.58
 CS group (19)02106.683.25
 Non-CS group (58)02108.342.20
 NRS at the end of the follow-up period    
 Total (77)02108.612.14
 CS group (19)02108.002.86
 Non-CS group (58)03108.811.84
  1. Note: OKC odontogenic keratocyst, UAM unicystic ameloblastoma, DC dentigerous cyst, RC radicular cyst, CS Carnoy’s solution, NRS numeric rating scale